How 2026 Tau Imaging News May Affect Alzheimer’s Workups: What Family Caregivers Should Know About the News

Learn when doctors may order the new tau PET scan and what it means for your loved one's care plan.

The 2026 tau imaging news means a memory workup can now include an FDA-approved brain scan that shows tau tangles. Tau tangles are twisted protein deposits linked to Alzheimer's damage, and tau PET makes them visible on a scan.

On Aug. 14, 2026, the FDA approved TAUKLARIFY (florquinitau F-18, research name MK-6240) for brain PET imaging in adults with cognitive impairment being evaluated for Alzheimer's, according to the Lantheus approval announcement. The approval identifies tau neurofibrillary tangle pathology, not general memory change.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What changed this year?

Doctors already used amyloid tests, spinal fluid tests, blood tests, and clinical exams. Tau PET adds a direct picture of tau buildup. Lantheus said tau PET complements amyloid PET and other tools to give a fuller picture of Alzheimer's disease, according to the Lantheus approval announcement.

A second advance came from a head-to-head study. In the 682-person HEAD study at eight U.S. and Canada sites, MK-6240 found tau positivity more than twice as often as flortaucipir in amyloid-positive unimpaired people, 15 percent versus 6 percent, and more often in impaired people, 28 percent versus 16 percent, according to the Lancet HEAD study summary. The same comparison found stronger accuracy for separating Alzheimer's-related impairment from non-Alzheimer impairment.

Who might be offered the new scan?

The new option affects only adults with symptoms who are already being evaluated for Alzheimer's. It is not approved as general screening for people without memory concerns.

In practice, it usually comes after a clinical exam plus amyloid, spinal fluid, or blood p-tau217 testing. A blood marker is a measured protein in blood that helps point toward Alzheimer's. Ask the doctor what prior result prompted the tau-scan referral.

  • Memory loss or thinking changes are present
  • Alzheimer's is already being evaluated
  • The doctor wants tau information after other tests
  • A memory specialist or PET center can perform the scan

What does tau information add to care?

Amyloid shows one Alzheimer's protein. Tau shows another protein tied more closely to where damage is happening. Together, they help the doctor judge whether symptoms fit Alzheimer's.

That distinction matters when memory loss could come from another cause. A clearer fit can guide diagnosis, treatment choices, and planning for safety, work, driving, and support. It can also affect eligibility discussions for Alzheimer's treatments tied to amyloid and tau findings.

What limits should caregivers understand?

The FDA label states safety and effectiveness have not been established for non-Alzheimer's tauopathies. A tauopathy is a disease with abnormal tau in the brain outside typical Alzheimer's. Families should not expect the scan to sort out every tau-related disorder. Scan reading also needs care. UCSF researchers reported in Feb.

2026 that some flortaucipir signal in non-Alzheimer cases reflected iron and MAO-B-related off-target binding rather than tau. The new tracer performed better in the HEAD comparison, but results still require a specialist reader. Expect referral away from primary care. Lantheus said it would keep supporting drug-development programs while assessing broader commercial availability. Ask for the referral name, the preparation steps, and how results will be shared with the care team.


You Might Also Like

HelpDementia.com

Dementia, Alzheimer's, Caregiving & Healthy Aging Guidance

© 2026 HelpDementia.com. All rights reserved.

Educational information only. It is not medical advice and does not replace care from a qualified clinician.